Skip to main content
Kirsten Lyke, MD, Infectious Disease, Baltimore, MD

Kirsten Ellizabeth Lyke MD


Associate Professor, Medicine, University of Maryland School of Medicine

Join to view full profile
  • 22 S Greene StBaltimore, MD 21201

  • Phone+1 410-328-5793

  • Fax+1 410-328-0248

Join Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 8 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Kirsten Lyke, MD is an infectious disease specialist in Baltimore, Maryland. She is currently licensed to practice medicine in Maryland and Arizona. She is affiliated with University of Maryland Medical Center and is an Associate Professor at University of Maryland School of Medicine.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Infectious Disease, 1998 - 2001
  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine, 1992 - 1995
  • Georgetown University School of Medicine
    Georgetown University School of MedicineClass of 1992

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1998 - 2026
  • AZ State Medical License
    AZ State Medical License 1996 - 1999
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

Press Mentions

  • HMN 2025: How New Monoclonal Antibody Prevents Malaria Infection in Early Clinical Trial
    HMN 2025: How New Monoclonal Antibody Prevents Malaria Infection in Early Clinical TrialOctober 28th, 2025
  • Would You Get Sick in the Name of Science?
    Would You Get Sick in the Name of Science?January 28th, 2025
  • Building a Biomedical Research Enterprise That Leads to More Equity and Healthier Lives
    Building a Biomedical Research Enterprise That Leads to More Equity and Healthier LivesOctober 28th, 2024